Associations of serum cystatin C and its change with new-onset cardiovascular disease in Chinese general population

Sacco, 2016, The heart of 25 by 25: achieving the goal of reducing global and regional premature deaths from cardiovascular diseases and stroke, Circulation, 133, 10.1161/CIR.0000000000000395

Zhou, 2016, Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013, Lancet, 387, 251, 10.1016/S0140-6736(15)00551-6

Newman, 2002, Ann Clin Biochem, 39, 89, 10.1258/0004563021901847

Angelidis, 2013, Cystatin C: an emerging biomarker in cardiovascular disease, Curr Top Med Chem, 13, 164, 10.2174/1568026611313020006

Di Lullo, 2015, Chronic kidney disease and cardiovascular complications, Heart Fail Rev, 20, 259, 10.1007/s10741-014-9460-9

Gansevoort, 2013, Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention, Lancet, 382, 339, 10.1016/S0140-6736(13)60595-4

Lee, 2010, Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations, Circulation: Cardiovascular Quality and Outcomes, 3, 675

Bi, 2015, The association between elevated cystatin C levels with myocardial infarction: a meta-analysis, Int J Clin Exp Med, 8, 20540

Rifkin, 2010, Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly, Nephrol Dial Transplant, 25, 1560, 10.1093/ndt/gfp646

Astor, 2012, Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population, Am J Kidney Dis, 59, 653, 10.1053/j.ajkd.2011.11.042

Svensson-Färbom, 2014, Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease, J Intern Med, 275, 506, 10.1111/joim.12169

Arpegård, 2016, Cystatin C predicts incident cardiovascular disease in twins, J Am Heart Assoc, 5, 10.1161/JAHA.115.003085

Ito, 2011, The effect of including cystatin C or creatinine in a cardiovascular risk model for asymptomatic individuals: the multi-ethnic study of atherosclerosis, Am J Epidemiol, 174, 949, 10.1093/aje/kwr185

Beilby, 2010, Comparison of cystatin C and creatinine as predictors of cardiovascular events in a community-based elderly population, Clin Chem, 56, 799, 10.1373/clinchem.2009.135962

Toft, 2012, Cystatin C as risk factor for cardiovascular events and all-cause mortality in the general population. The Tromsø Study, Nephrol Dial Transplant, 27, 2780, 10.1093/ndt/gfr751

Svensson-Färbom, 2015, Cystatin C is not causally related to coronary artery disease, PLoS One, 10, 10.1371/journal.pone.0129269

van der Laan, 2016, Cystatin C and cardiovascular disease: a mendelian randomization study, J Am Coll Cardiol, 68, 934, 10.1016/j.jacc.2016.05.092

Zhang, 2021, Association of depressive symptoms with rapid kidney function decline in adults with normal kidney function, Clin J Am Soc Nephrol, 16, 889, 10.2215/CJN.18441120

Zhang, 2021, Association of estimated glomerular filtration rate from serum creatinine and cystatin C with new-onset diabetes: a nationwide cohort study in China, Acta Diabetol, 58, 1269, 10.1007/s00592-021-01719-5

Zhao, 2014, Cohort profile: the China health and retirement longitudinal study (CHARLS), Int J Epidemiol, 43, 61, 10.1093/ije/dys203

Jia, 2020, Association of renal function and depressive symptoms: evidence from the China health and retirement longitudinal study, J Psychosom Res, 137, 110224, 10.1016/j.jpsychores.2020.110224

Zhao, 2014

Shen, 2019, High-sensitivity C-reactive protein and cystatin C independently and jointly predict all-cause mortality among the middle-aged and elderly Chinese population, Clin Biochem, 65, 7, 10.1016/j.clinbiochem.2018.12.012

Cui, 2020, Effects of cystatin C on cognitive impairment in older Chinese adults, Am J Alzheimers Dis Other Demen, 35, 1311391213, 10.1177/1533317520965101

Zheng, 2022, Lower handgrip strength levels probably precede triglyceride glucose index and associated with diabetes in men not in women, J Diabetes Investig, 13, 148, 10.1111/jdi.13626

Luo, 2018, Obesity and the onset of depressive symptoms among middle-aged and older adults in China: evidence from the CHARLS, BMC Publ Health, 18, 909, 10.1186/s12889-018-5834-6

Levey, 2009, A new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006

Li, 2019, Association of depressive symptoms with incident cardiovascular diseases in middle-aged and older Chinese adults, JAMA Netw Open, 2, 10.1001/jamanetworkopen.2019.16591

Patel, 2009, Association of cystatin C with left ventricular structure and function: the Dallas Heart Study, Circ Heart Fail, 2, 98, 10.1161/CIRCHEARTFAILURE.108.807271

Liu, 2004, Lysosomal cysteine proteases in atherosclerosis, Arterioscler Thromb Vasc Biol, 24, 1359, 10.1161/01.ATV.0000134530.27208.41

Frostegard, 2013, Immunity, atherosclerosis and cardiovascular disease, BMC Med, 11, 117, 10.1186/1741-7015-11-117

Einwoegerer, 2018, Association between increased levels of cystatin C and the development of cardiovascular events or mortality: a systematic Review and meta-analysis, Arq Bras Cardiol, 111, 796

Benoit, 2020, Cystatin C as a biomarker of chronic kidney disease: latest developments, Expert Rev Mol Diagn, 20, 1019, 10.1080/14737159.2020.1768849

Kühn, 2021, Kidney function as risk factor and predictor of cardiovascular outcomes and mortality among older adults, Am J Kidney Dis, 77, 386, 10.1053/j.ajkd.2020.09.015

Go, 2004, Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization, N Engl J Med, 351, 1296, 10.1056/NEJMoa041031

Shlipak, 2006, Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease, Ann Intern Med, 145, 237, 10.7326/0003-4819-145-4-200608150-00003

Shlipak, 2005, Cystatin-C and inflammatory markers in the ambulatory elderly, Am J Med, 118, 1416, 10.1016/j.amjmed.2005.07.060

Knight, 2004, Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement, Kidney Int, 65, 1416, 10.1111/j.1523-1755.2004.00517.x

Golia, 2014, Inflammation and cardiovascular disease: from pathogenesis to therapeutic target, Curr Atherosclerosis Rep, 16, 435, 10.1007/s11883-014-0435-z

Glymour, 2009, Can self-reported strokes be used to study stroke incidence and risk factors?: evidence from the health and retirement study, Stroke, 40, 873, 10.1161/STROKEAHA.108.529479

Xie, 2019, Cognitive decline before and after incident coronary events, J Am Coll Cardiol, 73, 3041, 10.1016/j.jacc.2019.04.019

Violán, 2013, Comparison of the information provided by electronic health records data and a population health survey to estimate prevalence of selected health conditions and multimorbidity, BMC Publ Health, 13, 251, 10.1186/1471-2458-13-251

Engstad, 2000, Validity of self-reported stroke: the tromso study, Stroke, 31, 1602, 10.1161/01.STR.31.7.1602

Shi, 2021, The circadian syndrome predicts cardiovascular disease better than metabolic syndrome in Chinese adults, J Intern Med, 289, 851, 10.1111/joim.13204

Su, 2022, Low density lipoprotein cholesterol is associated with increased risk of cardiovascular disease in participants over 70 years old: a prospective cohort study, Nutr Metabol Cardiovasc Dis, 32, 447, 10.1016/j.numecd.2021.10.009

Cui, 2021, Sex-specific association of BMI change with stroke in middle-aged and older adults with type 2 diabetes, Nutr Metabol Cardiovasc Dis, 31, 3095, 10.1016/j.numecd.2021.07.007

Lu, 2021, Waist-to-height ratio, waist circumference, body mass index, waist divided by height(0.5) and the risk of cardiometabolic multimorbidity: a national longitudinal cohort study, Nutr Metabol Cardiovasc Dis, 31, 2644, 10.1016/j.numecd.2021.05.026

Zhang, 2019, Exposure to Chinese famine in early life modifies the association between hyperglycaemia and cardiovascular disease, Nutr Metabol Cardiovasc Dis, 29, 1230, 10.1016/j.numecd.2019.07.004